Liver, Lipids, and the Left Ventricle 🩸🫀🧬
The NEJM review reminds us that fatty liver isn't just a liver problem. MASLD drives risk for heart disease, diabetes, kidney dysfunction, and even cancers. 🚨
Cardiovascular disease remains the leading cause of death in MASLD—outpacing cirrhosis and cancer. 🫀💔
With new tools like FIB-4, VCTE, ELF, and promising drugs such as resmetirom and GLP-1/GIP agonists, we're entering an era where treating the liver can protect the heart. 💊🌱
#MASLD #LiverHeartConnection #NEJM #CardiometabolicHealth
